SGB-9768

· Suzhou Sanegene Bio Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SGB-9768, covering 2025-01-22 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SGB-9768 in Patients with Complement-mediated Kidney Diseases [Phase 2]